How was the ₹801 crore revenue split between segments?

Ayurvedic products contributed ₹415.68 crore and healthcare services added ₹383.40 crore. The two segments are nearly equal contributors to the top line.

Why did profit grow so much faster than revenue?

Revenue grew 71% but total expenses grew only 39% to ₹512.13 crore. That gap allowed profit to hit ₹222 crore, a 178% jump from ₹80 crore.

What does the ₹4.50 dividend represent?

It is a final dividend of ₹4.50 per equity share on a face value of ₹2, subject to shareholder approval.

What were the total expenses for FY26?

Total expenses rose to ₹512.13 crore from ₹368.23 crore a year earlier, a 39% increase.

Earnings · Trading · Mid cap

Jeena Sikho profit jumps 178% to ₹222 cr as costs lag revenue surge

Annual revenue grew 71% to ₹801 crore, but expenses rose only 39%. The board recommended a ₹4.50 per share final dividend.

— 1 earlier story on Jeena Sikho Lifecare Ltd. →

JSLL By Tipsheet Editorial 30 May 2026 · 8:05 PM IST Verify on BSE · NSE

Mkt cap₹8,605 cr

P/E38.73×

ROE33.23%

Debt / eq.0.04

Div yld0.65%

₹222 cr FY26 net profit, up 178% from ₹80 cr.

What's new

FY26 revenue grew 71% to ₹801 crore, with ayurvedic products and healthcare services contributing nearly equally.
Net profit surged 178% to ₹222 crore from ₹80 crore a year earlier.
The board recommended a final dividend of ₹4.50 per share on a ₹2 face value stock.

Why this matters

The profit surge is driven by a favourable cost dynamic: revenue is scaling much faster than the expense base. That operating leverage is the real story behind the triple-digit profit growth.

What we're watching

Whether the 71% revenue growth rate is sustainable as the base expands.
How the company manages a ₹512 crore expense base that grew 39%.
The final dividend yield once the stock price reacts to these results.

The full read

Jeena Sikho Lifecare's FY26 numbers mark a step-change in scale. Revenue hit ₹801 crore, up 71% year-on-year, with ayurvedic products and healthcare services contributing almost equally. Net profit surged 178% to ₹222 crore from ₹80 crore. The reason is simple: expenses rose just 39% to ₹512 crore, so the cost base is growing much slower than sales. The board is sharing the cash with a ₹4.50 final dividend on a ₹2 face value share. The open question is whether this cost structure holds as the revenue base crosses ₹800 crore. It's a strong result. The cost discipline is the key.

Questions answered

How was the ₹801 crore revenue split between segments?: Ayurvedic products contributed ₹415.68 crore and healthcare services added ₹383.40 crore. The two segments are nearly equal contributors to the top line.
Why did profit grow so much faster than revenue?: Revenue grew 71% but total expenses grew only 39% to ₹512.13 crore. That gap allowed profit to hit ₹222 crore, a 178% jump from ₹80 crore.
What does the ₹4.50 dividend represent?: It is a final dividend of ₹4.50 per equity share on a face value of ₹2, subject to shareholder approval.
What were the total expenses for FY26?: Total expenses rose to ₹512.13 crore from ₹368.23 crore a year earlier, a 39% increase.

Mentioned: Jeena Sikho Lifecare · ₹801 cr revenue · ₹222 cr net profit

Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

Story so far

All notes on JSLL →

30 May 2026 · 8:05 PM IST Jeena Sikho profit jumps 178% to ₹222 cr as costs lag revenue surge
1d ago Jeena Sikho kills Entero deal, guides ₹300 cr profit for FY27